BJDX (STOCKS)
Bluejay Diagnostics, Inc. Common Stock
$1.059400
+0.009400 (+0.90%)
Prev close: $1.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Indranil Dey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1.21M
- Employees
- 5
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $99.60K |
| Operating Expenses | $7.00M |
| Research and Development | $3.07M |
| Other Operating Expenses | $3.93M |
| Operating Income/Loss | -$7.00M |
| Income/Loss From Continuing Operations After Tax | -$6.90M |
| Income/Loss From Continuing Operations Before Tax | $24.40M |
| Net Income/Loss | -$6.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$15.00 |
| Diluted Earnings Per Share | -$15.00 |
| Basic Average Shares | 3,223,476 |
| Diluted Average Shares | 3,223,476 |
| Assets | $5.60M |
| Current Assets | $3.97M |
| Noncurrent Assets | $1.63M |
| Fixed Assets | $1.53M |
| Other Non-current Assets | $102.33K |
| Liabilities | $1.42M |
| Current Liabilities | $1.41M |
| Accounts Payable | $220.29K |
| Other Current Liabilities | $1.19M |
| Noncurrent Liabilities | $3.49K |
| Equity | $4.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.18M |
| Liabilities And Equity | $5.60M |
| Net Cash Flow From Operating Activities | -$6.46M |
| Net Cash Flow From Operating Activities, Continuing | -$6.46M |
| Net Cash Flow From Investing Activities | -$1.37M |
| Net Cash Flow From Investing Activities, Continuing | -$1.37M |
| Net Cash Flow From Financing Activities | $7.22M |
| Net Cash Flow From Financing Activities, Continuing | $7.22M |
| Net Cash Flow | -$617.49K |
| Net Cash Flow, Continuing | -$617.49K |
| Comprehensive Income/Loss | -$6.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.90M |
| Other Comprehensive Income/Loss | $0.00 |